Tarsus Corporate Presentation August 12, 2024 Tarsus Second Quarter 2024 Earnings Presentation August 9, 2024 Ersa Phase 2a Study Evaluating TP-03 for the Treatment of MGD in Patients with DemodexMites Topline Data Presentation December 11, 2023 XDEMVY Approval Webcast Presentation July 25, 2023 Creating the Next Potential Blockbuster Category in Eye Care June 15, 2023 Tarsus Saturn-2 Phase 3 Trial Topline Results Presentation May 4, 2022 Revolutionizing Treatment for Demodex Blepharitis Patients Webcast Presentation February 10, 2022
Ersa Phase 2a Study Evaluating TP-03 for the Treatment of MGD in Patients with DemodexMites Topline Data Presentation December 11, 2023